354 related articles for article (PubMed ID: 10544113)
1. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
2. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
3. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
[TBL] [Abstract][Full Text] [Related]
4. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
Maury W; Bradley S; Wright B; Hines R
Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL
J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
[TBL] [Abstract][Full Text] [Related]
6. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
7. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
8. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
[TBL] [Abstract][Full Text] [Related]
10. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.
Maury W; Perryman S; Oaks JL; Seid BK; Crawford T; McGuire T; Carpenter S
J Virol; 1997 Jul; 71(7):4929-37. PubMed ID: 9188555
[TBL] [Abstract][Full Text] [Related]
11. Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies.
Reis JK; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
Virology; 2003 Jun; 311(1):169-80. PubMed ID: 12832214
[TBL] [Abstract][Full Text] [Related]
12. Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada.
Nagarajan MM; Simard C
Virus Res; 2007 Nov; 129(2):228-35. PubMed ID: 17767972
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus.
Madden CR; Shih DS
Virology; 1996 Nov; 225(2):395-9. PubMed ID: 8918926
[TBL] [Abstract][Full Text] [Related]
14. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
Leroux C; Craigo JK; Issel CJ; Montelaro RC
J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
16. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
Lichtenstein DL; Issel CJ; Montelaro RC
J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
[TBL] [Abstract][Full Text] [Related]
17. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
[TBL] [Abstract][Full Text] [Related]
18. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
Leroux C; Cadoré JL; Montelaro RC
Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
[TBL] [Abstract][Full Text] [Related]
19. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
[TBL] [Abstract][Full Text] [Related]
20. Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism.
Payne SL; La Celle K; Pei XF; Qi XM; Shao H; Steagall WK; Perry S; Fuller F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():755-759. PubMed ID: 10092016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
